News Articles Tagged: Preclinical Efficacy

Ipatasertib in Vivo: Demonstrating Antitumor Activity in Preclinical Models

Examine the in vivo efficacy of Ipatasertib in preclinical cancer models, highlighting its antitumor effects and the critical role of PUMA.

Preclinical Insights: Selinexor's Anti-Tumor Efficacy in Leukemia Models

Delve into the preclinical evidence demonstrating Selinexor's anti-tumor efficacy in leukemia models, highlighting its potential and the role of companies like NINGBO INNO PHARMCHEM CO.,LTD. in providing research materials.

The Pharmacological Profile of Galunisertib: Mechanism, Efficacy, and PK/PD Insights

Delve into the detailed pharmacological profile of Galunisertib (CAS 700874-72-2), including its mechanism of action as a TGF-beta Receptor I inhibitor, preclinical efficacy, and pharmacokinetic/pharmacodynamic insights.

The Safety and Efficacy Profile of BAM15: A Mitochondrial Uncoupler for Therapeutic Use

Examine the safety and efficacy of BAM15, a mitochondrial uncoupler, detailing its preclinical findings on tolerability, bioavailability, and therapeutic potential.

The Evolving Landscape of Cancer Drug Discovery: Insights from AZD5991

NINGBO INNO PHARMCHEM CO.,LTD. shares insights into cancer drug discovery, highlighting the development and potential of AZD5991 as a next-generation Mcl-1 inhibitor.